Abrucomstat
CAS No. 100502-66-7
Abrucomstat( —— )
Catalog No. M35037 CAS No. 100502-66-7
Abrucomstat (3-NOP) (3-Nitroxypropanol) functions as an enzyme inhibitor, effectively reducing ruminal methanogenesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 60 | In Stock |
|
| 5MG | 54 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 276 | In Stock |
|
| 100MG | 462 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1004 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAbrucomstat
-
NoteResearch use only, not for human use.
-
Brief DescriptionAbrucomstat (3-NOP) (3-Nitroxypropanol) functions as an enzyme inhibitor, effectively reducing ruminal methanogenesis.
-
DescriptionAbrucomstat (3-Nitroxypropanol) is an orally active methyl coenzyme M reductase inhibitor. Abrucomstatdecreases ruminal methanogenesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number100502-66-7
-
Formula Weight121.09
-
Molecular FormulaC3H7NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (825.83 mM; Ultrasonic)DMSO : 100 mg/mL (825.83 mM; Ultrasonic )
-
SMILESOCCCO[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
gp100 (619-627)
gp100 (619-627)
-
26Rfa, Hypothalamic ...
This human neuropeptide of the RFamide peptide family with orexigenic activity may be also involved in the control of feeding behavior. The 26RFa gene is exclusively expressed in the ventromedial hypothalamic nucleus and in the lateral hypothalamic area. The primary structures of human, rat, and frog 26RFa exhibit ≈80% identity. Other data suggest also the potential role of the 26RFa peptide in the control of the gonadotropic axis.
-
Rhamnazin
Rhamnazin is an orally active inhibitor of VEGFR2 signaling with an IC50 of 4.68 μM against VEGFR2 kinase. Rhamnazin shows potent antiangiogenic activity and antitumor efficacy. Rhamnazin shows antioxidant and anti-inflammatory properties.
Cart
sales@molnova.com